Short-Course vs Long-Course Antibiotic Therapy for Children with Nonsevere Community-Acquired Pneumonia

JAMA Pediatrics: Published on November 2022

A Systematic Review and Meta-analysis

TAKE-HOME MESSAGE

Are shorter courses of antibiotics as good as longer courses?

This systematic review and meta-analysis assessed whether shorter courses of antibiotics are noninferior to longer courses of antibiotics for nonsevere community-acquired pneumonia (CAP) in children.

The studies included compared 3-day courses with 5- to 10-day courses and 5-day courses with 7- to 10-day courses; the outcomes evaluated included treatment failure, post-treatment fever, hospitalization, antibiotic change, and death.

In this systematic review and meta-analysis of 11,143 children with nonsevere community-acquired pneumonia, more than 95% of the participants were aged 2 to 59 months, and treatment failure occurred in 12.8% vs 12.6% of those randomized to a shorter vs a longer course of antibiotics.

The results showed that a 3-day course was noninferior to a 5-day course and that a 5-day course was noninferior to a 10-day course, with shorter courses being associated with lower rates of gastroenteritis and caregiver absenteeism.

In children with nonsevere CAP, providers should consider prescribing a shorter course (3–5 days) of antibiotics. Short courses are not only noninferior to longer courses but reduce the incidence of adverse drug effects and treatment costs and likely increase treatment adherence.


Doctors Liked to Read More

Importance: Short-course antibiotic therapy could enhance adherence and reduce adverse drug effects and costs. However, based on sparse evidence, most guidelines recommend a longer course of antibiotics for nonsevere childhood community-acquired pneumonia (CAP).

Objective: To determine whether a shorter course of antibiotics was noninferior to a longer course for childhood nonsevere CAP.

Data sources: MEDLINE, Embase, Web of Science, the Cochrane Library, and 3 Chinese databases from inception to March 31, 2022, as well as clinical trial registries and Google.com.

Study selection: Randomized clinical trials comparing a shorter- vs longer-course therapy using the same oral antibiotic for children with nonsevere CAP were included.

Data extraction and synthesis: Random-effects models were used to pool the data, which were analyzed from April 15, 2022, to May 15, 2022. Grading of Recommendations Assessment, Development and Evaluation (GRADE) was used to rate the quality of the evidence.

Main outcomes and measures: Treatment failure, defined by persistence of pneumonia or the new appearance of any general danger signs of CAP (eg, lethargy, unconsciousness, seizures, or inability to drink), elevated temperature (>38 °C) after completion of treatment, change of antibiotic, hospitalization, death, missing more than 3 study drug doses, loss to follow-up, or withdrawal of informed consent.

Results: Nine randomized clinical trials including 11 143 participants were included in this meta-analysis. A total of 98% of the participants were aged 2 to 59 months, and 58% were male. Eight studies with 10 662 patients reported treatment failure. Treatment failure occurred in 12.8% vs 12.6% of participants randomized to shorter vs a longer course of antibiotics. High-quality evidence showed that a shorter course of oral antibiotic was noninferior to a longer course with respect to treatment failure for children with nonsevere CAP. A 3-day course of antibiotic treatment was noninferior to a 5-day course for the outcome of treatment failure, and a 5-day course was noninferior to a 10-day course. A shorter course of antibiotics was associated with fewer reports of gastroenteritis and lower caregiver absenteeism.

Conclusions and relevance: Results of this meta-analysis suggest that a shorter course of antibiotics was noninferior to a longer course in children aged 2 to 59 months with nonsevere CAP. Clinicians should consider prescribing a shorter course of antibiotics for the management of pediatric nonsevere CAP.

Read In Details


https://pubmed.ncbi.nlm.nih.gov/36374480/
https://jamanetwork.com/journals/jamapediatrics/article-abstract/2798514

This is for informational purposes only. You should consult your clinical textbook for advising your patients.